ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 081

Predicting Extension in Juvenile Idiopathic Arthritis

Megan Simonds1, Kathleen Sullivan2 and AnneMarie Brescia1, 1Nemours Children's Health, Wilmington, DE, 2Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2023 Pediatric Rheumatology Symposium

Keywords: Fibroblasts, Synovial, Gene Expression, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, March 30, 2023

Title: Posters: Genetics and Pathogenesis I

Session Type: Poster Session A

Session Time: 6:00PM-7:00PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood and carries a risk of permanent joint damage and disability [1]. In adult rheumatoid arthritis (RA), early aggressive treatment can lead to remission. This may also be true for JIA in children; however, treatment paradigms in JIA remain reactive rather than proactive due to lack of reliable methods to predict extension to a polyarticular course. Our objective was to validate cell subpopulations using flow cytometry to predict which patients have a high likelihood of extending.

Methods: JIA FLS cell lines from oligoarticular (oligo), extended-to-be (ETB), and polyarticular (poly) types were cultured. Flow cytometry was performed by Raybiotech, Inc. scRNA-seq was performed by Genewiz according to 10x Genomics Chromium protocols. SeuratR package was used for QC, analysis, and exploration of data.

Results: Fibroblast-like synoviocytes are heterogeneous. Cells from scRNA-seq were annotated using SingleR data package. Subpopulation percentages were calculated from cell counts (Figure 1). Smooth muscle cell-like cells (SMC) decreased in poly (p 0.05 in oligo v poly). Fibroblast-like cell (FLS) percentage was higher in ETB than oligo (p 0.05). Chondrocyte-like cells (CH) percentage increased in poly compared to oligo and ETB (p 0.05). We performed flow cytometry on normal cell lines to determine if traditional markers for CH, SMC, and FLS can distinguish these cell types from one another. These markers did not confidently isolate these cell types (Figure 2). As a result, we analyzed our scRNA-seq data for markers that could distinguish JIA subtypes via flow cytometry (CH – SMOC2, SOX9; FLS – IGFBP4, VCAN; SMC – CD309). These markers could not distinguish FLS from CH using flow. We revisited gene data from scRNA-seq. Seurat single analysis identified the top genes of each projected cell type for each subtype. Genes that contribute the most variation among cells within a JIA subtype are as follows: oligo – COL1A1, MT-ND1, TUBA1B, ACAN, and IFI27, ETB – MTRNR2LB, SERPINE1, TOP2A, MEG3, COL3A1, and VCAM, poly – ACP5, SPP1, TNFAIP6, IGFBP5, AKAP12, MFAP5, and S100A4 (Figure 3).

Conclusion: While flow cytometry has proven unable to distinguish between cell subpopulations within FLS cultures, these cell subpopulations have unique genetic fingerprints with transcript expression levels that can be used to distinguish JIA subtypes.

1. Manners, P.J. and C. Bower, Worldwide prevalence of juvenile arthritis why does it vary so much? The Journal of rheumatology, 2002. 29(7): p. 1520-1530.

The authors wish to acknowledge CARRA and the ongoing Arthritis Foundation financial support of CARRA.

Supporting image 1Figure 1. Percentage of FLS subpopulations in cultured FLS from patients with oligoarticular (Oligo), extended-to-be (ETB), and polyarticular (Poly) JIA. The percentage of smooth muscle-cell-like cells decreases in more severe subtypes of JIA; fibroblast-like cells significantly increased in ETB compared to Oligo; and chondrocyte-like cells increases in more severe subtypes of JIA. ^p < 0.0006 Oligo vs. Poly; *p=0.03 Oligo vs. ETB; p=0.0044 ETB vs. Poly.

Supporting image 2Table 1. Traditional markers from literature to distinguish cell types. Expected outcomes based on literature (A). Actual outcomes based on flow cytometry (B).

Supporting image 3Figure 3. Genes that are the highest contributors to variation among subpopulations. Genes that contribute the most variation among cell subpopulations are as follows: oligo – COL1A1, MT-ND1, TUBA1B, ACAN, and IFI27, ETB – MTRNR2LB, SERPINE1, TOP2A, MEG3, COL3A1, and VCAM, poly – ACP5, SPP1, TNFAIP6, IGFBP5, AKAP12, MFAP5, and S100A4


Disclosures: M. Simonds: None; K. Sullivan: None; A. Brescia: None.

To cite this abstract in AMA style:

Simonds M, Sullivan K, Brescia A. Predicting Extension in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 4). https://acrabstracts.org/abstract/predicting-extension-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predicting-extension-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology